The physiological performance of a three-dimensional model that mimics the microenvironment of the small intestine

Biomaterials

Volumn 32, Issue 30, 2011, Pages 7469-7478

  Pusch, Jacqueline ^a   Votteler, Miriam ^a,b   Göhler, Stella ^a   Engl, Jasmin ^a   Hampel, Martina ^a,c   Walles, Heike ^a,d   Schenke Layland, Katja ^a,b  

^a FRAUNHOFER INSTITUTE FOR INTERFACIAL ENGINEERING AND BIOTECHNOLOGY IGB   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF STUTTGART   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Cell morphology; Co culture; ECM (extracellular matrix); Epithelial cell; In vitro test; Organ culture

Indexed keywords

CELL MORPHOLOGY; COCULTURE; ECM (EXTRACELLULAR MATRIX); EPITHELIAL CELLS; IN VITRO TEST; ORGAN CULTURE;

BIOREACTORS; CELL CULTURE; ENDOTHELIAL CELLS; ENZYME ACTIVITY; GLYCOPROTEINS; MORPHOLOGY; PHYSIOLOGICAL MODELS; PHYSIOLOGY; TISSUE;

THREE DIMENSIONAL;

DESMOPRESSIN; FLUORESCEIN; GLYCOPROTEIN P;

ARTICLE; BIOLOGICAL MODEL; BIOREACTOR; CELL CULTURE; CELL DIFFERENTIATION; CELL STRAIN CACO 2; CELL STRUCTURE; CELL TRANSPORT; COCULTURE; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INTERMETHOD COMPARISON; INTESTINE CELL; INTESTINE MUCOSA PERMEABILITY; JEJUNUM; MICROENVIRONMENT; MICROVASCULAR ENDOTHELIAL CELL; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN TRANSPORT; SMALL INTESTINE ABSORPTION; THREE DIMENSIONAL TISSUE MODEL; TISSUE ENGINEERING;

BIOREACTORS; CACO-2 CELLS; CELLS, CULTURED; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; HUMANS; INTESTINAL ABSORPTION; INTESTINE, SMALL; MODELS, BIOLOGICAL;

SUS;

EID: 80051546370     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.06.035     Document Type: Article

References (63)

1. Pfrunder A., Gutmann H., Beglinger C., Drewe J. Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines. J Pharm Pharmacol 2003, 55:59-66.
2. Le Ferrec E., Chesne C., Artusson P., Brayden D., Fabre G., Gires P., et al. In vitro models of the intestinal barrier. The report and recommendations of ECVAM workshop 46. European Centre for the validation of alternative methods. Altern Lab Anim 2001, 29:649-668.
3. Ungell A.L. Transport studies using intestinal tissue ex vivo. Cell culture models of biological barriers: in-vitro test systems for drug absorption and delivery 2002, 164-188. Taylor & Francis, London, New York. C.M. Lehr (Ed.).
4. Steward B.H., Chan H.O., Jezyk N., Fleisher D. Discrimination between oral drug candidates using models for evaluation of intestinal absorption. Adv Drug Deliver Rev 1997, 23:27-45.
5. Hartung T. Thoughts on limitations of animal models. Parkinsonism Relat Disord 2008, 14(Suppl. 2):S81-S83.
6. Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. OJ vol. 276, 20.10.2010, pp. 33-79.
7. Deferme S., Annaert D., Augustijs P. In vitro screening models to assess intestinal drug absorption metabolism. Drug absorption studies in situ, in vitro and in silico models 2002, 182-215. Springer, New York. C. Erhardt, K.J. Kim (Eds.).
8. Braun A., Hammerle S., Suda K., Rothen-Rutishauser B., Gunthert M., Kramer S.D., et al. Cell cultures as tools in biopharmacy. Eur J Pharm Sci 2000, 11(Suppl. 2):S51-S60.
9. Artursson P., Palm K., Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliver Rev 2001, 46:27-43.
10. Hu M., Ling J., Lin H., Chen J. Use of Caco-2 cell monolayers to study drug absorption and metabolism. Methods in pharmacology and toxicology optimization in drug discovery: in vitro methods 2004, 19-35. Humana Press, New York. Z. Yan, G.W. Caldwell (Eds.).
11. Karlsson J., Ungell A., Grasjo J., Artursson P. Paracellular drug transport across intestinal epithelia: influence of charge and induced water flux. Eur J Pharm Sci 1999, 9:47-56.
12. Meunier V., Bourrie M., Berger Y., Fabre G. The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications. Cell Biol Toxicol 1995, 11:187-194.
13. Shirasaka Y., Kawasaki M., Sakane T., Omatsu H., Moriya Y., Nakamura T., et al. Induction of human P-glycoprotein in Caco-2 cells: development of a highly sensitive assay system for P-glycoprotein-mediated drug transport. Drug Metab Pharmacok 2006, 21:414-423.
14. Sun D., Lennernas H., Welage L.S., Barnett J.L., Landowski C.P., Foster D., et al. Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs. Pharm Res-Dordr 2002, 19:1400-1416.
15. Zakelj S., Legen I., Veber M., Kristl A. The influence of buffer composition on tissue integrity during permeability experiments "in vitro" Int J Pharm 2004, 272:173-180.
16. Markowska M., Oberle R., Juzwin S., Hsu C.P., Gryszkiewicz M., Streeter A.J. Optimizing Caco-2 cell monolayers to increase throughput in drug intestinal absorption analysis. J Pharmacol Toxicol Methods 2001, 46:51-55.
17. Lennernäs H. Intestinal permeability and its relevance for absorption and elimination. Xenobiotica 2007, 37:1015-1051.
18. Chen H.C., Hu Y.C. Bioreactors for tissue engineering. Biotechnol Lett 2006, 28:1415-1423.
19. Cukierman E., Pankov R., Stevens D.R., Yamada K.M. Taking cell-matrix adhesions to the third dimension. Science 2001, 294:1708-1712.
20. Minuth W.W., Denk L., Glashauser A. A modular culture system for the generation of multiple specialized tissues. Biomaterials 2010, 31:2945-2954.
21. Schenke-Layland K., Nsair A., Van Handel B., Angelis E., Gluck J.M., Votteler M., et al. Recapitulation of the embryonic cardiovascular progenitor cell niche. Biomaterials 2011, 32:2748-2756.
22. Richard L., Velasco P., Detmar M. A simple immunomagnetic protocol for the selective isolation and long-term culture of human dermal microvascular endothelial cells. Exp Cell Res 1998, 240:1-6.
23. Mertsching H., Walles T., Hofmann M., Schanz J., Knapp W.H. Engineering of a vascularized scaffold for artificial tissue and organ generation. Biomaterials 2005, 26:6610-6617.
24. Hamman J.H., Enslin G.M., Kotze A.F. Oral delivery of peptide drugs: barriers and developments. BioDrugs 2005, 19:165-177.
25. Konishi Y., Hagiwara K., Shimizu M. Transepithelial transport of fluorescein in Caco-2 cell monolayers and use of such transport in in vitro evaluation of phenolic acid availability. Biosci Biotechnol Biochem 2002, 66:2449-2457.
26. Troutman M.D., Thakker D.R. Rhodamine 123 requires carrier-mediated influx for its activity as a P-glycoprotein substrate in Caco-2 cells. Pharm Res-Dordr 2003, 20:1192-1199.
27. Artursson P., Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun 1991, 175:880-885.
28. Yamashita S., Tanaka Y., Endoh Y., Taki Y., Sakane T., Nadai T., et al. Analysis of drug permeation across Caco-2 monolayer: implication for predicting in vivo drug absorption. Pharm Res-Dordr 1997, 14:486-491.
29. Fogh J., Trempe G. New human tumor cell lines. Human tumor cells: "in vitro" 1975, 115-159. Plenum Press, New York. J. Fogh (Ed.).
30. Saaf A.M., Halbleib J.M., Chen X., Yuen S.T., Leung S.Y., Nelson W.J., et al. Parallels between global transcriptional programs of polarizing Caco-2 intestinal epithelial cells in vitro and gene expression programs in normal colon and colon cancer. Mol Biol Cell 2007, 18:4245-4260.
31. Cul M., Klopot A., Jiang Y., FLeet J.C. The effect of differentiation on 1,25 dihydroxyvitamin D-mediated gene expression in the enterocyte-like cell line, Caco-2. J Cell Physiol 2009, 113-121.
32. Leonard F., Collnot E.M., Lehr C.M. A three-dimensional coculture of enterocytes, monocytes and dendritic cells to model inflamed intestinal mucosa in vitro. Mol Pharmacol 2010, 7:2103-2119.
33. Banerjee P., Merkel G.J., Bhunia A.K. Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells. Gut Pathog 2009, 1:8.
34. Burkholder K.M., Bhunia A.K. Salmonella enterica serovar typhimurium adhesion and cytotoxicity during epithelial cell stress is reduced by Lactobacillus rhamnosus GG. Gut Pathog 2009, 1:14.
35. Gotz A., Eylert E., Eisenreich W., Goebel W. Carbon metabolism of enterobacterial human pathogens growing in epithelial colorectal adenocarcinoma (Caco-2) cells. PLoS One 2010, 5:e10586.
36. Naresh R., Song Y., Hampson D.J. The intestinal spirochete Brachyspira pilosicoli attaches to cultured Caco-2 cells and induces pathological changes. PLoS One 2009, 4:e8352.
37. Bibert S., Aebischer D., Desgranges F., Roy S., Schaer D., Kharoubi-Hess S., et al. A link between FXYD3 (Mat-8)-mediated Na, K-ATPase regulation and differentiation of Caco-2 intestinal epithelial cells. Mol Biol Cell 2009, 20:1132-1140.
38. Sanders M.A., Ampasala D., Basson M.D. DOCK5 and DOCK1 regulate Caco-2 intestinal epithelial cell spreading and migration on collagen IV. J Biol Chem 2009, 284:27-35.
39. Weerachayaphorn J., Pajor A.M. Identification of transport pathways for citric acid cycle intermediates in the human colon carcinoma cell line, Caco-2. Biochim Biophys Acta 2008, 1778:1051-1059.
40. Driss A., Charrier L., Yan Y., Nduati V., Sitaraman S., Merlin D. Dystroglycan receptor is involved in integrin activation in intestinal epithelia. Am J Physiol-Gastr L 2005, 290:G11228-G11242.
41. Boyer J., Brown D., Liu R.H. In vitro digestion and lactase treatment influence uptake of quercetin and quercetin glucoside by the Caco-2 cell monolayer. Nutr J 2005, 4:1.
42. Fujita H., Sugimoto K., Inatomi S., Maeda T., Osanai M., Uchiyama Y., et al. Tight junction proteins claudin-2 and -12 are critical for vitamin D-dependent Ca2+ absorption between enterocytes. Mol Biol Cell 2008, 19:1912-1921.
43. Smetanova L., Stetinova V., Svoboda Z., Kvetina J. Caco-2 cells, biopharmaceutics classification system (BCS) and biowaiver. Acta Med (Hradec Kralove) 2011, 54:3-8.
44. Wood K.M., Stone G.M., Peppas N.A. The effect of complexation hydrogels on insulin transport in intestinal epithelial cell models. Acta Biomater 2010, 6:48-56.
45. Simon-Assmann P., Turck N., Sidhoum-Jenny M., Gradwohl G., Kedinger M. In vitro models of intestinal epithelial cell differentiation. Cell Biol Toxicol 2007, 23:241-256.
46. Maringka M., Giri S., Bader A. Preclinical characterization of primary porcine hepatocytes in a clinically relevant flat membrane bioreactor. Biomaterials 2010, 31:156-172.
47. Schanz J., Pusch J., Hangmen J., Walles H. Vascularised human tissue models: a new approach for the refinement of biomedical research. J Biotechnol 2010, 148:56-63.
48. Masungi C., Mensch J., Willems B., Van Dijck A., Borremans C., Noppe M., et al. Usefulness of a novel Caco-2 cell perfusion system II. Characterization of monolayer properties and peptidase activity. Pharmazie 2009, 64:36-42.
49. Niklason L.E., Gao J., Abbott W.M., Hirschi K.K., Houser S., Marini R., et al. Functional arteries grown in vitro. Science 1999, 284:489-493.
50. Skalak T.C., Price R.J. The role of mechanical stresses in microvascular remodeling. Microcirculation 1996, 3:143-165.
51. Berginc K., Zakelj S., Levstik L., Ursic D., Kristl A. Fluorescein transport properties across artificial lipid membranes, Caco-2 cell monolayers and rat jejunum. Eur J Pharm Biopharm 2007, 66:281-285.
52. Masungi C., Borremans C., Willems B., Mensch J., Van Dijck A., Augustijns P., et al. Usefulness of a novel Caco-2 cell perfusion system. I. In vitro prediction of the absorption potential of passively diffused compounds. J Pharm Sci 2004, 93:2507-2521.
53. Yumoto R., Murakami T., Nakamoto Y., Hasegawa R., Nagai J., Takano M. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds. J Pharmacol Exp Ther 1999, 289:149-155.
54. Evans G.S., Flint N., Somers A.S., Eyden B., Potten C.S. The development of a method for the preparation of rat intestinal epithelial cell primary cultures. J Cell Sci 1992, 101(Pt 1):219-231.
55. Fukamachi H. Proliferation and differentiation of fetal rat intestinal epithelial cells in primary serum-free culture. J Cell Sci 1992, 103(Pt 2):511-519.
56. Perreault N., Jean-Francois B. Use of the dissociating enzyme thermolysin to generate viable human normal intestinal epithelial cell cultures. Exp Cell Res 1996, 224:354-364.
57. Vidrich A., Ravindranath R., Farsi K., Targan S. A method for the rapid establishment of normal adult mammalian colonic epithelial cell cultures. In Vitro Cell Dev Biol 1988, 24:188-194.
58. Weiser M.M. Intestinal epithelial cell surface membrane glycoprotein synthesis. I. An indicator of cellular differentiation. J Biol Chem 1973, 248:2536-2541.
59. Cencic A., Langerholc T. Functional cell models of the gut and their applications in food microbiology-a review. Int J Food Microbiol 2010, 141(Suppl. 1):S4-S14.
60. Chopra D.P., Dombkowski A.A., Stemmer P.M., Parker G.C. Intestinal epithelial cells in vitro. Stem Cells Dev 2010, 19:131-142.
61. Montgomery R.K., Breault D.T. Small intestinal stem cell markers. J Anat 2008, 213:52-58.
62. von Furstenberg R.J., Gulati A.S., Baxi A., Doherty J.M., Stappenbeck T.S., Gracz A.D., et al. Sorting mouse jejunal epithelial cells with CD24 yields a population with characteristics of intestinal stem cells. Am J Physiol-Gastr L 2011, 300:G409-G417.
63. Spence J.R., Mayhew C.N., Rankin S.A., Kuhar M.F., Vallance J.E., Tolle K., et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 2011, 470:105-109.